How mRNA is misspliced in acute myelogenous leukemia (AML)? - Wikidata - awgldk - TriplyDB

How mRNA is misspliced in acute myelogenous leukemia (AML)?

How mRNA is misspliced in acute myelogenous leukemia (AML)?

http://www.wikidata.org/entity/Q38265600

about

Aberrant splicing and drug resistance in AML Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

P2860

Q28076011-A5AA6A55-F5B5-4197-B8EC-C36FDAE0EF0F Q36771977-98333B65-0C7C-4C7F-B3DD-533973CFC6E6

P2860

How mRNA is misspliced in acute myelogenous leukemia (AML)?

http://www.wikidata.org/entity/Q38265600

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

How mRNA is misspliced in acute myelogenous leukemia (AML)?

@en

type

label

How mRNA is misspliced in acute myelogenous leukemia (AML)?

@en

prefLabel

How mRNA is misspliced in acute myelogenous leukemia (AML)?

@en

P1433

Q38265600-C2F43025-657C-43F8-B491-C3A7CF9DC25D

P1476

Q38265600-344F55F5-B5B7-4063-92A0-7D75DDF49E6F

P2093

Q38265600-117C210E-99B9-4095-BEBE-E5829FA36194

Q38265600-2C6458BB-21C7-4A4A-BC1F-0A807C60C3C3

Q38265600-76814A94-DC01-446E-85AC-7F4E70F23F40

Q38265600-DB9543D7-1DBD-48D8-B183-8B825FC7D2D1

P275

Q38265600-4EF8FBE1-D780-4E30-AEEB-8B6A761D5EB0

P2860

Q38265600-02C51F6A-A175-4CBC-90B6-029713881C1D

Q38265600-04FCA3F6-21BA-4FFF-9D0C-007CAB4C79FE

Q38265600-08006C0A-6871-47C9-8AD6-03A834AEEF38

Q38265600-0A035D64-0035-4F98-A99B-A537F704B4F5

Q38265600-0B3D8A08-E9A3-47DA-90ED-55BE3A0B36F3

Q38265600-0BCD7D45-6278-487E-BEC9-4EC342C72B4F

Q38265600-0E16915C-F6F3-4B56-9216-20329CDCB917

Q38265600-0FD9B5D9-4833-460F-85E3-D3B4C4B1FC77

Q38265600-0FDF74B5-5BF5-46D1-8961-7861E5510056

Q38265600-1135AC83-9183-4EC6-A277-48B1D2749CAF

P304

Q38265600-66CA8B6B-7A69-413C-9289-E3374EFCE6E4

P31

Q38265600-0E9DC150-9C18-4B01-958B-EBA9FF452990

Q38265600-D19E3482-B5A7-46EB-90F2-F39FF50185E3

P356

Q38265600-B38450D5-D8F7-4124-8B45-D32FE666D19D

P407

Q38265600-FB121B8F-3B41-403F-A18D-5FADBDAFB524

P433

Q38265600-BCDE1A67-8610-4996-9275-CB7BC179BC80

P478

Q38265600-F8049FAA-7F62-437B-BA9D-886FC753C3FE

P50

Q38265600-35F19F4F-2CB0-4E6D-8AC6-C010C373F99C

Q38265600-43FB5410-1D20-42E4-BF09-7BA2B0D4AA94

P5008

Q38265600-E7E9077D-AA89-4637-A161-768857330BC9

P577

Q38265600-46B15862-44B9-43B0-A629-743B307D2515

Q38265600-D95E0C77-C7D8-4267-A3A2-62FCEADBB1BB

P698

Q38265600-D502061B-D38C-4A8C-83C8-60528AE2C264

P921

Q38265600-925E5E4E-3597-4441-AD45-EF7840EFF4B7

Q38265600-FA00B037-7EEA-4CCD-A2B3-C4FAB9960B88

P932

Q38265600-891E6648-B3DC-42A0-984E-119F9E97D356

P356

ONCOTARGET.2304

P1433

P1476

How mRNA is misspliced in acute myelogenous leukemia (AML)?

@en

P2093

Aminetou Mint Mohamed

http://www.w3.org/2001/XMLSchema#string

Eric Wattel

http://www.w3.org/2001/XMLSchema#string

Françoise Solly

http://www.w3.org/2001/XMLSchema#string

Marie Balsat

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion

Lark is the splicing factor RBM4 and exhibits unique subnuclear localization properties

WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

Epigenetics in alternative pre-mRNA splicing

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials

DNMT3A Mutations in Acute Myeloid Leukemia

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

SF3B1 mutations in chronic lymphocytic leukemia.

P304

9534-9545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2304

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Franck Mortreux

P5008

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25375204

http://www.w3.org/2001/XMLSchema#string

P921

acute myeloid leukemia

regulation of gene expression

P932

4259418

http://www.w3.org/2001/XMLSchema#string